What happened?
Researchers studied animal models, human brain tissue and cultured nerve cells. They found that abnormal tau could activate reverse electron transport in mitochondria. That process, in turn, promoted further changes in tau.
Why does it matter?
Interrupting the loop reduced several damaging effects in experimental models. This suggests a potential target for future research into diseases associated with abnormal tau.
How to interpret the evidence
The work helps explain a possible disease mechanism. Improvements in flies, mice or cultured cells do not establish effectiveness or safety in patients.
What remains uncertain?
The experimental compound is not a new proven treatment for Alzheimer’s disease or other tau-related disorders. The researchers say more work is required before clinical trials.
Medical News provides general health education. Individual treatment decisions depend on your circumstances and the advice of your clinical team.